{"disease":{"id":"short-stature","name":"short stature"},"drugs":{"marketed":[{"drug_id":"somapacitan-beco","indication_name":"Short stature SGA without catch-up growth","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"SOGROYA","generic_name":"SOMAPACITAN-BECO","company_name":"NOVO NORDISK INC","drug_phase":"marketed","molecular_target":"Growth hormone receptor","drug_class":"","quality_score":25,"revenue":null,"mechanism":""},{"drug_id":"somapacitan-beco","indication_name":"Idiopathic Short Stature","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"SOGROYA","generic_name":"SOMAPACITAN-BECO","company_name":"NOVO NORDISK INC","drug_phase":"marketed","molecular_target":"Growth hormone receptor","drug_class":"","quality_score":25,"revenue":null,"mechanism":""},{"drug_id":"somapacitan","indication_name":"Short stature, SGA without catch-up growth","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Sogroya","generic_name":"SOMAPACITAN","company_name":"Novo Nordisk","drug_phase":"marketed","molecular_target":"Growth hormone receptor","drug_class":"","quality_score":70,"revenue":null,"mechanism":"Sogroya works by binding to the growth hormone receptor, mimicking the action of growth hormone and stimulating growth and development."},{"drug_id":"somapacitan","indication_name":"Idiopathic Short Stature","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Sogroya","generic_name":"SOMAPACITAN","company_name":"Novo Nordisk","drug_phase":"marketed","molecular_target":"Growth hormone receptor","drug_class":"","quality_score":70,"revenue":null,"mechanism":"Sogroya works by binding to the growth hormone receptor, mimicking the action of growth hormone and stimulating growth and development."},{"drug_id":"ngenla-somatrogon","indication_name":"Idiopathic short stature in pediatric patients 2 years of age and older","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"NGENLA (Somatrogon)","generic_name":"ngenla-somatrogon","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Growth hormone receptor","drug_class":"Recombinant human growth hormone","quality_score":40,"revenue":null,"mechanism":""},{"drug_id":"ngenla-somatrogon","indication_name":"Short stature associated with Turner syndrome in pediatric patients 2 years of age and older","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"NGENLA (Somatrogon)","generic_name":"ngenla-somatrogon","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Growth hormone receptor","drug_class":"Recombinant human growth hormone","quality_score":40,"revenue":null,"mechanism":""},{"drug_id":"ngenla-somatrogon","indication_name":"Short stature associated with SHOX deficiency in pediatric patients 2 years of age and older","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"NGENLA (Somatrogon)","generic_name":"ngenla-somatrogon","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Growth hormone receptor","drug_class":"Recombinant human growth hormone","quality_score":40,"revenue":null,"mechanism":""},{"drug_id":"ngenla-somatrogon","indication_name":"Short stature associated with idiopathic growth hormone deficiency in pediatric patients 2 years of age and older","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"NGENLA (Somatrogon)","generic_name":"ngenla-somatrogon","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Growth hormone receptor","drug_class":"Recombinant human growth hormone","quality_score":40,"revenue":null,"mechanism":""},{"drug_id":"ngenla-somatrogon","indication_name":"Short stature associated with other causes of growth hormone deficiency in pediatric patients 2 years of age and older","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"NGENLA (Somatrogon)","generic_name":"ngenla-somatrogon","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Growth hormone receptor","drug_class":"Recombinant human growth hormone","quality_score":40,"revenue":null,"mechanism":""}],"pipeline":[],"offLabel":[],"totalMarketed":9,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06110910","title":"Long-term Efficacy and Safety Evaluation of Growth Hormone in Children in China(CGLS)","phase":"","overall_status":"RECRUITING","enrollment_count":10000,"lead_sponsor_name":"Xiaoping Luo","has_results":false},{"nct_id":"NCT04476433","title":"Intervention in Chronic Pediatric Patients and Their Families.","phase":"NA","overall_status":"COMPLETED","enrollment_count":500,"lead_sponsor_name":"University of Valencia","has_results":false},{"nct_id":"NCT04754516","title":"Diagnosis of Short Stature in Children : Study of a Cohort of Small-sized Consulting Patients","phase":"","overall_status":"COMPLETED","enrollment_count":479,"lead_sponsor_name":"University Hospital, Montpellier","has_results":false},{"nct_id":"NCT02311322","title":"Genetic Causes of Growth Disorders","phase":"","overall_status":"TERMINATED","enrollment_count":334,"lead_sponsor_name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)","has_results":false},{"nct_id":"NCT06309979","title":"A Study to Assess Growth in Children With Idiopathic Short Stature","phase":"","overall_status":"RECRUITING","enrollment_count":300,"lead_sponsor_name":"BioMarin Pharmaceutical","has_results":false},{"nct_id":"NCT03123003","title":"Bone Age Assessment in Children Using Ultrasound Compared to Wrist X-ray","phase":"NA","overall_status":"UNKNOWN","enrollment_count":300,"lead_sponsor_name":"Meir Medical Center","has_results":false},{"nct_id":"NCT06768411","title":"The Dosage Exploration Study of PEG-rhGH for Treating Short Stature in Prepubertal and Pubertal Children","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":240,"lead_sponsor_name":"Second Affiliated Hospital of Wenzhou Medical University","has_results":false},{"nct_id":"NCT05858606","title":"Multidisciplinary Evaluation and a Genome-wide Analysis in a Cohort of Idiopathic Short Stature Patients","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":200,"lead_sponsor_name":"University Hospital, Montpellier","has_results":false},{"nct_id":"NCT05829252","title":"Testing the Feasibility of a Novel Growth Monitoring Smartphone App","phase":"","overall_status":"COMPLETED","enrollment_count":146,"lead_sponsor_name":"Queen Mary University of London","has_results":false},{"nct_id":"NCT07450053","title":"A Study (Phase 1b/2) of GenSci134 in Children With Idiopathic Short Stature (ISS)","phase":"PHASE1, PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":128,"lead_sponsor_name":"Changchun GeneScience Pharmaceutical Co., Ltd.","has_results":false},{"nct_id":"NCT03015909","title":"Evaluation of the Ease of Use, Preference, and Safety of EutropinPen Inj.","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":116,"lead_sponsor_name":"LG Life Sciences","has_results":false},{"nct_id":"NCT06295341","title":"Short Stature and Psychological Well-being","phase":"","overall_status":"COMPLETED","enrollment_count":80,"lead_sponsor_name":"Istituto Auxologico Italiano","has_results":false},{"nct_id":"NCT02137538","title":"Aromatase Inhibitor Growth Study: Letrozole vs. Anastrozole","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":79,"lead_sponsor_name":"Stanford University","has_results":true},{"nct_id":"NCT05838885","title":"A Trial of YPEG-rhGH in Children With Short Stature","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":78,"lead_sponsor_name":"Xiamen Amoytop Biotech Co., Ltd.","has_results":false},{"nct_id":"NCT02826902","title":"Effect of Anesthesia on Quality of Recovery in Patients Undergoing Correctional Tibial Osteotomy - A Randomized Controlled Trial","phase":"NA","overall_status":"COMPLETED","enrollment_count":76,"lead_sponsor_name":"Yonsei University","has_results":false},{"nct_id":"NCT07260500","title":"A Phase II Study of PEG-rhGH Injection for Short Children Born Small for Gestational Age: Efficacy, Safety, and Pharmacokinetics","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":72,"lead_sponsor_name":"Changchun GeneScience Pharmaceutical Co., Ltd.","has_results":false},{"nct_id":"NCT03878446","title":"A Research Study in Children Born Small and Who Stayed Small. Treatment is Somapacitan Once a Week Compared to Norditropin® Once a Day","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":62,"lead_sponsor_name":"Novo Nordisk A/S","has_results":true},{"nct_id":"NCT04219007","title":"Vosoritide for Selected Genetic Causes of Short Stature","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":56,"lead_sponsor_name":"Andrew Dauber","has_results":false},{"nct_id":"NCT01778023","title":"Efficacy and Safety of Recombinant Human Growth Hormone on Height Velocity in Subjects With Idiopathic Short Stature","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":54,"lead_sponsor_name":"Novo Nordisk A/S","has_results":true},{"nct_id":"NCT03575221","title":"Natural History of the Collagen-Related Disorder Osteogenesis Imperfecta and Genotype Phenotype Correlation","phase":"","overall_status":"COMPLETED","enrollment_count":46,"lead_sponsor_name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)","has_results":false},{"nct_id":"NCT04020913","title":"Skeletal Muscle Effects of GH in Boys","phase":"","overall_status":"COMPLETED","enrollment_count":45,"lead_sponsor_name":"Nemours Children's Clinic","has_results":false},{"nct_id":"NCT04244123","title":"Web-based Adherence Information Integrated Nurse-led Monitoring Clinic","phase":"","overall_status":"COMPLETED","enrollment_count":43,"lead_sponsor_name":"Manchester University NHS Foundation Trust","has_results":false},{"nct_id":"NCT05894876","title":"A Study of the Genetic Basis of Response to Growth Hormone Treatment in Children With Idiopathic Short Stature","phase":"","overall_status":"TERMINATED","enrollment_count":43,"lead_sponsor_name":"Novo Nordisk A/S","has_results":false},{"nct_id":"NCT01237041","title":"Free Fatty Acids, Body Weight, and Growth Hormones Secretion in Children","phase":"PHASE1, PHASE2","overall_status":"TERMINATED","enrollment_count":37,"lead_sponsor_name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)","has_results":true},{"nct_id":"NCT01401244","title":"Bioequivalence of Two Somatropin Products (Norditropin® Versus Genotropin®) in Healthy Adult Volunteers","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":30,"lead_sponsor_name":"Novo Nordisk A/S","has_results":false},{"nct_id":"NCT03288103","title":"Growth Hormone Treatment in Patients With Aggrecan (ACAN) Deficiency","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":22,"lead_sponsor_name":"Children's Hospital Medical Center, Cincinnati","has_results":true},{"nct_id":"NCT00102258","title":"Role of Nutrition and Hormones in Boys With Disordered Growth","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":20,"lead_sponsor_name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)","has_results":false},{"nct_id":"NCT06294860","title":"Biological Age in Children With GH Deficiency Undergoing Hormone Replacement Therapy","phase":"","overall_status":"COMPLETED","enrollment_count":10,"lead_sponsor_name":"Istituto Auxologico Italiano","has_results":false},{"nct_id":"NCT02636270","title":"IGF-1 Treatment for Individuals With Short Stature Due to PAPP-A2 Deficiency","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":7,"lead_sponsor_name":"Children's Hospital Medical Center, Cincinnati","has_results":true},{"nct_id":"NCT04275141","title":"Mauriac Syndrome: Isotopic Techniques and Genetic Analysis","phase":"NA","overall_status":"COMPLETED","enrollment_count":6,"lead_sponsor_name":"University of Lausanne","has_results":false},{"nct_id":"NCT06372366","title":"Oral Manifestations in Egyptian Children With Short Stature","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":2,"lead_sponsor_name":"Cairo University","has_results":false}],"total":31},"guidelines":[],"source":"Drug Landscape verified database"}